Wednesday, Nov 25th

Last update04:28:52 AM GMT

You are here News Health FDA staff note deaths in Pfizer bone drug study

FDA staff note deaths in Pfizer bone drug study

E-mail Print PDF
A higher percentage of patients treated with an experimental Pfizer Inc drug for osteoporosis died during a clinical trial compared with a placebo, U.S. drug reviewers said in an analysis released on Thursday.

The higher proportion of deaths through five years was statistically significant only for the lowest dose of the drug called Fablyn, said Food and Drug Administration reviewers. More patients given Fablyn, which was co-developed with Ligand Pharmaceuticals Inc, also developed blood clots.


Most Recent Related Stories...

Frank Gifford suffered from brain disease CTE, family says

Frank Gifford had CTEPro Football Hall of Famer Frank Gifford, who died this past summer of natural causes, suffered...

CDC says E. coli outbreak linked to Chipotle restaurants now involves six states

Chipolte E.coli outbreak is in six statesAn outbreak of E. coli that was first reported in the Pacific Northwest and linked to...

Federal Court: Restrictive WI Abortion Law Is Unconstitutional, Endangers Women's Health

Wisc. abortion law unconstitutionalA Wisconsin law that requires abortion providers to get admitting privileges at nearby hospitals is unconstitutional,...

Doctors from 44 countries call on Ireland to relax abortion laws

Doctors ask Ireland toe ase abortion restrictionsHundreds of doctors from 44 countries including some of Ireland’s most prominent physicians have called on...
America's # 1 Enemy
Tee Shirt
& Help Support!
TVNL Tee Shirt
Conserve our Planet
& Help Support!
Get your 9/11 & Media
Deception Dollars
& Help Support!
The Loaded Deck
The First & the Best!
The Media & Bush Admin Exposed!